Company intelligence / Profile preview

Stern Investor Relations

New York, New York, United Statesbuiltinnyc.com ↗

Ownership: Private
Employees: ~43
Development stage: Other

Overview

Stern Investor Relations (Stern IR) provides strategic investor relations and communications consulting for biotechnology and healthcare companies across all stages of development. The firm does not develop drugs or have its own clinical pipeline but supports over 70 client companies in the sector with capital markets strategy, messaging, and stakeholder engagement.

Industry: Consulting

Partnerships

Antibe Therapeutics (as client)

Beyond the preview

Go deeper on Stern Investor Relations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stern Investor Relations.

Explore the full profile